$2.58 1.2%
EAR Stock Price vs. AI Score (Last 150 days)
Data gathered: June 22

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Eargo

Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States.

Price $2.58
Target Price Sign up
Volume 201,300
Market Cap $53M
Year Range $1.6 - $70.5
Dividend Yield 0%
PE Ratio 0.17
Revenue per Employee $169,169
Industry Medical Devices

In the news

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '238.3M22M4.3M-17M-18M-0.835
Q2 '238.1M29M1.6M-25M-26M-1.080
Q1 '2312M30M5.1M-22M-23M-0.900
Q4 '2213M33M6.2M-44M-24M-4.180
Q3 '227.9M29M1.9M-51M-26M-24.200

Insider Transactions View All

Thorpe Mark filed to sell 1,064 shares at $3.2.
August 17 '23
Laponis Adam filed to sell 3,152 shares at $3.2.
August 17 '23
Brownie William filed to sell 8,279 shares at $3.2.
August 17 '23
Brownie William filed to sell 6,779 shares at $3.2.
August 17 '23
Thorpe Mark filed to sell 1,067 shares at $4.7.
May 18 '23

What is the Market Cap of Eargo?

The Market Cap of Eargo is $53M.

What is Eargo's PE Ratio?

As of today, Eargo's PE (Price to Earnings) ratio is 0.17.

How Many People Work at Eargo?

As of our latest update, Eargo employed approximately 243 people worldwide. However, it's important to note that Eargo's workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Eargo's revenue per employee?

$169,169. To calculate Eargo's revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of Eargo?

Currently, the price of one share of Eargo stock is $2.58.

How can I analyze the EAR stock price chart for investment decisions?

The EAR stock price chart above provides a comprehensive visual representation of Eargo's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Eargo shares. Our platform offers an up-to-date EAR stock price chart, along with technical data analysis and alternative data insights.

Does EAR offer dividends to its shareholders?

As of our latest update, Eargo (EAR) does not offer dividends to its shareholders. Investors interested in Eargo should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Eargo?

Some of the similar stocks of Eargo are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.